{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:46Z","timestamp":1793725846990,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12072-022-10461-1","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T05:04:42Z","timestamp":1671080682000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Ilaria","family":"Barchetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Agata","family":"Cimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Passarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Dellanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Di Biasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Leonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Silecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gisella","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"1","key":"10461_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 2018;27(1):22\u201341","journal-title":"Cell Metab"},{"issue":"1","key":"10461_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"2","key":"10461_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14(2):99\u2013114","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10461_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903\u2013913","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10461_CR5","doi-asserted-by":"publisher","first-page":"235060","DOI":"10.1155\/2014\/235060","volume":"2014","author":"V Locatelli","year":"2014","unstructured":"Locatelli V, Bianchi VE. Effect of GH\/IGF-1 on bone metabolism and osteoporsosis. Int J Endocrinol. 2014;2014:235060","journal-title":"Int J Endocrinol."},{"key":"10461_CR6","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.81.P768","author":"S Turgut","year":"2022","unstructured":"Turgut S, Acarer D, Seyit H, Pamuk N, et al. Insulin-like growth factor-i might be a predictor for severe non-alcoholic fatty liver disease in morbidly obese patients. Horm Metab Res. 2022. https:\/\/doi.org\/10.1530\/endoabs.81.P768","journal-title":"Horm Metab Res"},{"issue":"3","key":"10461_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-0043-124970","volume":"50","author":"S Liang","year":"2018","unstructured":"Liang S, Yu Z, Song X, Wang Y, Li M, Xue J. Reduced growth hormone secretion is associated with nonalcoholic fatty liver disease in obese children. Horm Metab Res. 2018;50(3):250\u2013256","journal-title":"Horm Metab Res"},{"issue":"9","key":"10461_CR8","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/dom.14774","volume":"24","author":"ID Vachliotis","year":"2022","unstructured":"Vachliotis ID, Anastasilakis AD, Goulas A, Goulis DG, Polyzos SA. Nonalcoholic fatty liver disease and osteoporosis: a potential association with therapeutic implications. Diabetes Obes Metab. 2022;24(9):1702","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10461_CR9","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1210\/clinem\/dgab262","volume":"106","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Muraca E, Zerbini F, Manzoni G. G. NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general us population. J Clin Endocrinol Metab. 2021;106(8):e2856\u2013e2865","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10461_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12072-021-10254-y","volume":"15","author":"JW Yoon","year":"2021","unstructured":"Yoon JW, Kim MJ, Chung GE, et al. Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease. Hepatol Int. 2021;15(6):1347\u20131355","journal-title":"Hepatol Int"},{"issue":"6","key":"10461_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s11914-021-00715-6","volume":"19","author":"V Van Hulten","year":"2021","unstructured":"Van Hulten V, Rasmussen N, Driessen JHM, Burden AM, Kvist A, van den Bergh JP. Fracture patterns in type 1 and type 2 diabetes mellitus: a narrative review of recent literature. Curr Osteoporos Rep. 2021;19(6):644\u2013655","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"10461_CR12","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3390\/jcm11082206","volume":"11","author":"JI Mart\u00ednez-Montoro","year":"2022","unstructured":"Mart\u00ednez-Montoro JI, Garc\u00eda-Fontana B, Garc\u00eda-Fontana C, Mu\u00f1oz-Torres M. Evaluation of quality and bone microstructure alterations in patients with type 2 diabetes: a narrative review. J Clin Med. 2022;11(8):2206","journal-title":"J Clin Med"},{"issue":"1","key":"10461_CR13","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.2337\/dc20-S001","volume":"43","author":"AD Association","year":"2020","unstructured":"Association AD. 1. improving care and promoting health in populations: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(1):S7\u2013S13","journal-title":"Diabetes Care"},{"issue":"1","key":"10461_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40618-021-01612-6","volume":"45","author":"I Barchetta","year":"2022","unstructured":"Barchetta I, Dule S, Bertoccini L, et al. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight\/obese children: a long-term follow-up study. J Endocrinol Invest. 2022;45(1):43\u201351","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10461_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137(3):865\u2013872","journal-title":"Gastroenterology"},{"key":"10461_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:1\u20137","journal-title":"BMC Gastroenterol"},{"key":"10461_CR17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/hepr.12647","volume":"46","author":"W Sun","year":"2016","unstructured":"Sun W, Cui H, Li N, Wei Y, Lai S, Yang Y, et al. Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study. Hepatol Res. 2016;46:862\u2013870","journal-title":"Hepatol Res"},{"issue":"2","key":"10461_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68(2):305\u2013315","journal-title":"J Hepatol"},{"issue":"3","key":"10461_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29(3):518\u2013530","journal-title":"J Bone Miner Res"},{"key":"10461_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017;112:740\u2013751","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10461_CR21","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/ajcn\/nqac059","volume":"115","author":"S Ciardullo","year":"2022","unstructured":"Ciardullo S, Oltolini A, Cannistraci R, Muraca E, Perseghin G. Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population. Am J Clin Nutr. 2022;115(6):1528\u20131534. https:\/\/doi.org\/10.1093\/ajcn\/nqac059 (PMID: 35244676)","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10461_CR22","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.3390\/ijms22052604","volume":"22","author":"YJ Yang","year":"2021","unstructured":"Yang YJ, Kim DJ. An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic sarcopenia. Int J Mol Sci. 2021;22(5):2604","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10461_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.molmed.2013.05.006","volume":"19","author":"G Musso","year":"2013","unstructured":"Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol Med. 2013;19(9):522\u2013535","journal-title":"Trends Mol Med"},{"key":"10461_CR24","doi-asserted-by":"publisher","first-page":"917861647","DOI":"10.1155\/2021\/9178616","volume":"2021","author":"M Zhang","year":"2021","unstructured":"Zhang M, Nie X, Yuan Y, et al. Osteocalcin alleviates nonalcoholic fatty liver disease in mice through GPRC6A. Int J Endocrinol. 2021;2021:917861647","journal-title":"Int J Endocrinol."},{"issue":"4","key":"10461_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jbmr.4227","volume":"36","author":"M Xia","year":"2021","unstructured":"Xia M, Rong S, Zhu X, et al. Osteocalcin and non-alcoholic fatty liver disease: lessons from two population-based cohorts and animal models. J Bone Miner Res. 2021;36(4):712\u2013728","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10461_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3961\/jpmph.20.089","volume":"53","author":"J Sung","year":"2020","unstructured":"Sung J, Ryu S, Song YM, Cheong HK. Relationship between non-alcoholic fatty liver disease and decreased bone mineral density: a retrospective cohort study in Korea. J Prev Med Public Health. 2020;53(5):342\u2013352","journal-title":"J Prev Med Public Health"},{"issue":"2","key":"10461_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41(2):261\u2013270","journal-title":"Liver Int"},{"key":"10461_CR28","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016. 64(6):1388\u2013402."},{"key":"10461_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2020.11.003","volume":"231","author":"L Miele","year":"2021","unstructured":"Miele L, Alberelli MA, Martini M, Liguori A, Marrone G, Cocomazzi A, et al. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. Transl Res. 2021;231:24\u201338. https:\/\/doi.org\/10.1016\/j.trsl.2020.11.003","journal-title":"Transl Res"},{"issue":"6","key":"10461_CR30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","volume":"41","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Perseghin G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int. 2021;41(6):1290\u20131293","journal-title":"Liver Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10461-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T04:36:12Z","timestamp":1681965372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10461-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10461"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10461-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ilaria Barchetta, Carla Lubrano, Flavia Agata Cimini, Sara Dule, Giulia Passarella, Arianna Dellanno, Alberto Di Biasio, Frida Leonetti, Gianfranco Silecchia, Andrea Lenzi, Maria Gisella Cavallo declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Sapienza University, Rome, Italy) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}